Multicentre treatment planning inter-comparison in a national context: The liver stereotactic ablative radiotherapy case-Reference-Cited by-同舟云学术

Multicentre treatment planning inter-comparison in a national context: The liver stereotactic ablative radiotherapy case

Published:2016-01 Issue:1 Volume:32 Page:277-283
ISSN:1120-1797
Container-title:Physica Medica
language:en
Short-container-title:Physica Medica

Author:

Esposito Marco,Maggi Giulia,Marino Carmelo,Bottalico Laura,Cagni Elisabetta,Carbonini Claudia,Casale Michelina,Clemente Stefania,D'Alesio Valentina,Fedele David,Giglioli Francesca Romana,Landoni Valeria,Martinotti Anna,Nigro Roberta,Strigari Lidia^ORCID,Villaggi Elena,Mancosu Pietro

Publisher

Elsevier BV

Subject

General Physics and Astronomy,Radiology Nuclear Medicine and imaging,General Medicine,Biophysics

Reference24 articles.

1. Stereotactic body radiation therapy in multiple organ sites;Timmerman;J Clin Oncol,2007

2. A rationale for the targeted treatment of oligometastases with radiotherapy;Macdermed;J Surg Oncol,2008

3. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases;Schefter;Int J Radiat Oncol Biol Phys,2005

4. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases;Katz;Int J Radiat Oncol Biol Phys,2007

5. Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial;Scorsetti;Int J Radiat Oncol Biol Phys,2013

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver function and image evaluation after radiotherapy for liver metastases after resection of sigmoid colon cancer a case report;International Journal of Surgery Case Reports;2024-03

2. Treatment Planning for Hypofractionated RT and SRS/SBRT;Hypofractionated and Stereotactic Radiation Therapy;2024

3. Real-world effectiveness and safety of stereotactic body radiotherapy for liver metastases with different respiratory motion management techniques;Strahlentherapie und Onkologie;2023-09-20

4. The role of EPID in vivo dosimetry in the risk management of stereotactic lung treatments;Strahlentherapie und Onkologie;2023-05-31

5. Dose prescription and reporting in stereotactic body radiotherapy: A multi-institutional study;Radiotherapy and Oncology;2023-05